Vaxart receives $3.3M for oral vaccines
See our story about this San Francisco biotech in today’s daily briefing at VenturBeat Life Sciences.
Next Story: Silicon Clocks raises $8M more for chip timing
Previous Story: Politics 2.0 — nowhere to be found
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.